A novel therapeutic target for preventing Helicobacter pylori-associated diseases [ 2017 - 2019 ]

Research Grant

Researchers: Prof Philip Sutton (Principal investigator) ,  Dr Trevelyan Menheniott ,  Prof Hazel Mitchell

Brief description Gastric cancer mainly results from chronic inflammation (gastritis) caused by the stomach-dwelling bacterium, Helicobacter pylori. We have identified a potassium channel which our data suggest could be a new therapeutic target for protecting against gastric cancer caused by H. pylori infection. This project will test the role of this channel in H. pylori gastritis and see whether drugs that target this channel can protect mice against H. pylori-associated disease.

Funding Amount $AUD 768,083.85

Funding Scheme Project Grants

Notes Standard Project Grant